STEM Minnesota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Minnesota.

Press releases published on July 24, 2026

2 hours ago

Nordic Naturals Releases Expert Insights on Why Omega-3s Should Be on Back-to-School Checklists

Indeterminate GlobeNewswire

2 hours ago

Purple named finalist in the Lloyds British Business Excellence Awards 2026

Indeterminate GlobeNewswire

2 hours ago

Self Inspection Raises $10 Million to Build the System of Record for Vehicle Condition

Indeterminate GlobeNewswire

3 hours ago

Physician Reviewer Networks: How Leading Health Plans Are Solving the Challenge Without Sacrificing Quality

Indeterminate GlobeNewswire

3 hours ago

Fly.io Doubles Down on Computers for Agents with $25M to Deliver the Next Generation of AI Infrastructure

Indeterminate GlobeNewswire

3 hours ago

HoneyPezil Publishes Updated 2026 Product Information for Its Brain Health and Memory Support Capsules

Indeterminate GlobeNewswire

4 hours ago

San Jose Science Center Scales Hands-On Engineering Education Across Kenya

Indeterminate GlobeNewswire

4 hours ago

Finland's 2027 Licensing Reform: Policy Implications for Europe by Pikakasinot

Indeterminate GlobeNewswire

5 hours ago

Quantum X Labs Reports Meaningful Error Correction Decoder Results with NVIDIA CUDA-Q QEC

Indeterminate GlobeNewswire

5 hours ago

Subcutaneous PD-1 Inhibitors Transition from Novelty to Routine Care as Oncologists Tailor Use by Tumor Type, According to Spherix Global Insights

Indeterminate GlobeNewswire

5 hours ago

Hormuz diversions plateau at 4x baseline as Navi Mumbai dwell rises to 21 days

Indeterminate GlobeNewswire

5 hours ago

NEZGLYAL® (leriglitazone) receives a positive CHMP opinion for the treatment of cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease

Indeterminate GlobeNewswire

6 hours ago

NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)

Indeterminate GlobeNewswire

6 hours ago

Immutep Announces Abstract Accepted for Presentation at the European Society for Medical Oncology (ESMO) Congress 2026

Indeterminate GlobeNewswire

6 hours ago

BiomX Subsidiary Zorronet Expands European Presence Through Two Strategic Collaborations in Europe

Indeterminate GlobeNewswire

7 hours ago

Dyadic Announces Continued Listing on the Nasdaq Capital Market

Indeterminate GlobeNewswire

7 hours ago

SPIRIT BLOCKCHAIN CAPITAL APPOINTS SUHA ASKARY AS CHIEF EXECUTIVE OFFICER

Indeterminate GlobeNewswire

7 hours ago

Persica Pharmaceuticals presents new analyses of microbiology assay sensitivity and intradiscal antibiotic exposure response in chronic Low Back Pain at ASPN 2026 Annual Conference

Indeterminate GlobeNewswire

7 hours ago

Asimov Joins the Genesis Mission, Using Boston University's NSF-Backed Cloud Lab to Power Lab-in-the-Loop AI Models

Indeterminate GlobeNewswire

7 hours ago

ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET

Indeterminate GlobeNewswire